Evidence map›Paper›PMID 18334793›Full record

ArticleIndian journal of pediatrics2008

NPHS2 mutations.

Ashraf Bakr, Soheir Yehia, Doaa El-Ghannam, Ayman Hammad, Mohamed Ragab, Amr Sarhan, Fatma Al-Husseni, Zakaria Al-Morsy

Abstract read
PubMed Publisher
In one paragraph

Article in Indian journal of pediatrics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Rituximab for refractory cases of childhood nephrotic syndrome.Pediatric nephrology (Berlin, Germany) · 2011
    Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ashraf BakrDepartment of Pediatric Nephrology, Mansoura University Children's Hospital, Mansoura, Egypt. ashbakr@mans.edu.eg
Soheir Yehia
Doaa El-Ghannam
Ayman Hammad
Mohamed Ragab
Amr Sarhan
Fatma Al-Husseni
Zakaria Al-Morsy
Children's Hospital Mansoura University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo uncover the frequency and the spectrum of NPHS2 mutations in Egyptian children with non familial steroid-resistant nephrotic syndrome (SRNS).

methodsSixteen patients were screened by PCR-single-strand conformation polymorphism analysis of NPHS2 gene followed by direct sequencing.

resultsNPHS2 mutations were evident in four patients (25%) who were bearing four novel mutations including two frame shift mutations (R238fs and P45fs) and two missense mutations (I136L and F216Y). There were no phenotypic or histological characteristics of patients bearing NPHS2 mutations, apart from the earlier onset of the disease, compared to those who were not bearing mutations.

conclusionNPHS2 mutations are prevalent in Egyptian children with non-familial SRNS and this may in part explain the less favorable prognosis reported in these patients.

Indexed as

MutationChildChild, PreschoolCross-Sectional StudiesEgyptFrameshift MutationGenetic MarkersHumansInfantIntracellular Signaling Peptides and ProteinsMembrane ProteinsMutation, MissenseNephrotic SyndromePolymerase Chain ReactionPolymorphism, Single-Stranded ConformationalPrevalenceGenetic MarkersIntracellular Signaling Peptides and ProteinsMembrane ProteinsNPHS2 protein

Identifiers

PMID18334793
OpenAlexW3190390687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.